Instead prostate-specific membrane antigen positron emission tomography (PSMA-PET) is emerging as a promising technique to improve tumor lesion detection [8–15], focal therapy guidance [16], and non-invasive PCa characterization [17]. This evidence concerns the gene FOLH1 and neoplasm.